Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer
Authors:
- Allen R. ChauvenetACAllen R. Chauvenet
- Antonio R. Perez-AtaydeAPAntonio R. Perez-Atayde
- Julia CruzJCJulia Cruz
- Robert McKoneRMRobert McKone
- Steven E. LipshultzSLSteven E. Lipshultz
- 1 January 1990
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 116 (1) , 144-147
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Cardiopulmonary Function in Long-Term Survivors of Childhood Hodgkin's Lymphoma: A Pilot StudyMayo Clinic Proceedings, 1988
- Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and reviewThe American Journal of Medicine, 1986
- Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in childrenCancer, 1981
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood.Circulation, 1978
- The cardiotoxicity of adriamycin and daunomycin in childrenCancer, 1976